Patents Assigned to MAT MALTA ADVANCED TECHNOLOGIES LIMITED
  • Patent number: 9801938
    Abstract: The present invention relates to the use of a composition selected from the group consisting of antibodies, antibody fragments, insulin-like growth factor antagonists, Toll-like receptor antagonists and mixtures thereof for the treatment or the prophylaxis of certain diseases.
    Type: Grant
    Filed: March 28, 2012
    Date of Patent: October 31, 2017
    Assignees: MAT-MALTA ADVANCED TECHNOLOGIES LIMITED, FREISTAAT BAYERN REPRESENTED BY JULIUS-MAXIMILLIANS-UNIVERSITÄT WÜRZBURG
    Inventors: Jan Wesjohann, Günter Sprotte, Ana Maria Waaga-Gasser
  • Publication number: 20150136030
    Abstract: The present disclosure relates to a device for delivering substances to specific embryonic structures, including heart and blood vessels, within a developing avian egg. The disclosure also relates to methods of using the device to produce enhanced avian embryos. Methods include administering to chicken embryos various substances, including vaccines, nutrients, and stem cells. Chickens resulting from enhanced avian embryos have advantages, including greater growth potential and resistance to pathogen infection/infestation.
    Type: Application
    Filed: October 17, 2014
    Publication date: May 21, 2015
    Applicants: MAT Malta Advanced Technologies Limited, Merial Limited
    Inventors: Sven Meissner, Stefan Geissler, Toni Frohnert, Doreen Goehler, Bjoern Fischer
  • Publication number: 20140112937
    Abstract: The present invention relates to the use of a composition selected from the group consisting of antibodies, antibody fragments, insulin-like growth factor antagonists, Toll-like receptor antagonists and mixtures thereof for the treatment or the prophylaxis of certain diseases.
    Type: Application
    Filed: March 28, 2012
    Publication date: April 24, 2014
    Applicants: FREISTAAT BAYERN REPRESENTED BY JULIUS- -MAXIMILIANS-UNIVERSITAT WURZBURG, MAT-MALTA ADVANCED TECHNOLOGIES LIMITED
    Inventors: Jan Wesjohann, Günter Sprotte, Ana Maria
  • Publication number: 20140099328
    Abstract: Antibody product comprising n-specific antibodies characterized in that a) the n-specific antibodies in each case have an antibody content of at least 6/n % by weight of the total antibody component of the antibody product, and b) 2, 3 or more of the n-specific antibodies target lipopolysaccharide-expressing microorganisms, and c) the total amount of n-specific antibodies is 7% by weight of the total anti-body content of the antibody product.
    Type: Application
    Filed: March 28, 2012
    Publication date: April 10, 2014
    Applicant: MAT-MALTA ADVANCED TECHNOLOGIES LIMITED
    Inventor: Jan Wesjohann
  • Publication number: 20140069336
    Abstract: In one embodiment, a process and method of screening an avian embryo feather color (pre-hatching) and determining the sex of the avian embryo, based at least in part, on the feather color or the color of feather precursors is provided. In an alternate embodiment, a process and method of screening chick embryo sex is provided, comprising the steps of: (i) obtaining a chicken egg; (ii) exposing the chicken egg to, or contacting the chicken egg with, electromagnetic radiation emitted from an electromagnetic radiation source; (iii) determining the amount of absorption, diffusion, refraction, reflection or a combination of any of the forgoing, of the electromagnetic radiation by the chicken egg by using an imaging system; (iv) comparing the absorption, diffusion, refraction, reflection or a combination of any of the forgoing, of the electromagnetic radiation by the chicken egg to a database; and (v) determining the sex of the chick embryo in the chicken egg, at least in part, as a result of the comparing step.
    Type: Application
    Filed: August 27, 2013
    Publication date: March 13, 2014
    Applicant: MAT MALTA ADVANCED TECHNOLOGIES LIMITED
    Inventor: James C. McKay